Ranger Investment Management, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001319691

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q3 2026 · 85 positions · Total reported value $1.07B · Top-10 concentration 27.4% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.9% · 13 new · 46 cut · 11 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -9.8% · vs SPY -12.0% · Prev Value $1.58B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.4% · vs SPY -1.7% · Latest Value $1.07B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Ranger Investment Management, L.P. disclosed 85 equity positions with a combined reported value of $1.07B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 27.4% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q3 2026 were LGND ($57.99M), PDFS ($38.27M), WLDN ($27.55M). By sector, the heaviest allocations are Health Care 29.2%, Consumer Discretionary 22.7%. Versus the prior quarter, allocation shifted toward Health Care (+8.6pp), Utilities (+0.6pp) and away from Consumer Staples (-0.6pp), Consumer Discretionary (-1.3pp).

Versus the prior quarter, Ranger Investment Management, L.P. opened 13 new positions, trimmed 46 and fully exited 11, a turnover rate of 72.9% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q3 2026 were KRYS ($12.16M), PTGX ($11.60M), HALO ($11.03M).

Of the 11 positions fully exited versus the prior quarter, the largest were AAON ($30.57M), PEGA ($26.17M), WSC ($24.08M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • KRYS KRYSTAL BIOTECH INC · $12.16M
  • PTGX PROTAGONIST THERAPEUTICS INC · $11.60M
  • HALO HALOZYME THERAPEUTICS INC · $11.03M
  • TCBI TEXAS CAP BANCSHARES INC · $9.77M
  • ALNT ALLIENT INC · $9.73M
  • MTDR MATADOR RES CO · $9.62M
  • TGTX TG THERAPEUTICS INC · $8.39M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $8.25M

Fully Exited (vs previous quarter)

  • AAON AAON INC · prev qtr: $30.57M
  • PEGA PEGASYSTEMS INC · prev qtr: $26.17M
  • WSC WILLSCOT HLDGS CORP · prev qtr: $24.08M
  • JLL JONES LANG LASALLE INC · prev qtr: $21.78M
  • PR PERMIAN RESOURCES CORP · prev qtr: $15.03M
  • GNRC GENERAC HLDGS INC · prev qtr: $14.35M
  • MEDP MEDPACE HLDGS INC · prev qtr: $14.23M
  • CELH CELSIUS HLDGS INC · prev qtr: $13.63M

Insider Transactions (Form 4)

Latest Ranger Investment Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Ranger Investment Management, L.P., based in Dallas, TX, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $1.58B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: DALLAS, TX, United States
  • SEC registration: 801-62397 (status: Approved), registered 2003-10-23
  • Regulatory AUM (Form ADV): $1.48B as of 2026-03-25
  • Client mix (by RAUM): pension and profit-sharing plans 64%, registered investment companies 34%
  • Manages 1 private funds
  • Website: rangerinvestments.com

Portfolio Structure

  • 83 positions · $1.58B reported value (Q2 2026)
  • Top 10 holdings = 30.2% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 5.2%
  • Average position size: $19.05M

Sector Tilt

  • Consumer Discretionary 24.0%
  • Health Care 20.6%
  • Information Technology 16.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 11 new, 19 added, 52 reduced, 7 exited
  • 1 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 29.2%
Technology 13.3%
Industrials 12.8%
Financials 8.8%
Utilities 6.5%
Energy 5.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 185.65K $57.99M 5.44%
5.44%
Reduce
2 749.66K $38.27M 3.59%
3.59%
Reduce
3 372.95K $27.55M 2.58%
2.58%
Add
4 380.24K $27.07M 2.54%
2.54%
Reduce
5 968.49K $26.90M 2.52%
2.52%
Reduce
6 830.60K $26.69M 2.50%
2.50%
Reduce
7 548.99K $23.95M 2.25%
2.25%
Reduce
8 367.36K $22.04M 2.07%
2.07%
Reduce
9 321.88K $21.12M 1.98%
1.98%
Reduce
10 226.00K $20.68M 1.94%
1.94%
Add
11 948.35K $19.90M 1.87%
1.87%
Reduce
12 221.32K $19.58M 1.84%
1.84%
Reduce
13 268.63K $19.52M 1.83%
1.83%
Reduce
14 232.38K $18.67M 1.75%
1.75%
Reduce
15 693.61K $18.48M 1.73%
1.73%
Reduce
16 107.35K $18.34M 1.72%
1.72%
Reduce
17 53.42K $17.83M 1.67%
1.67%
Reduce
18 215.50K $17.80M 1.67%
1.67%
Reduce
19 157.13K $17.41M 1.63%
1.63%
Reduce
20 94.94K $17.10M 1.60%
1.60%
Reduce
21 131.43K $17.08M 1.60%
1.60%
Reduce
22 118.72K $16.93M 1.59%
1.59%
Reduce
23 926.53K $16.80M 1.58%
1.58%
Reduce
24 486.46K $16.60M 1.56%
1.56%
Add
25 531.62K $16.27M 1.53%
1.53%
Add
26 1.60M $16.02M 1.50%
1.50%
Reduce
27 514.45K $14.47M 1.36%
1.36%
Reduce
28 204.25K $13.60M 1.28%
1.28%
Reduce
29 45.89K $13.54M 1.27%
1.27%
Reduce
30 47.05K $13.40M 1.26%
1.26%
Reduce
31 336.01K $13.40M 1.26%
1.26%
Reduce
32 459.80K $13.38M 1.26%
1.26%
Add
33 231.54K $12.40M 1.16%
1.16%
Reduce
34 36.56K $12.16M 1.14%
1.14%
New
35 788.40K $11.67M 1.09%
1.09%
Reduce
36 82.36K $11.60M 1.09%
1.09%
New
37 213.94K $11.24M 1.05%
1.05%
Reduce
38 129.09K $11.06M 1.04%
1.04%
Reduce
39 99.89K $11.03M 1.03%
1.03%
New
40 98.89K $10.56M 0.99%
0.99%
Reduce
41 292.30K $10.45M 0.98%
0.98%
Hold
42 86.54K $10.43M 0.98%
0.98%
Reduce
43 252.54K $9.85M 0.92%
0.92%
Hold
44 105.07K $9.77M 0.92%
0.92%
New
45 87.21K $9.73M 0.91%
0.91%
New
46 62.17K $9.72M 0.91%
0.91%
Reduce
47 186.55K $9.62M 0.90%
0.90%
New
48 109.82K $9.57M 0.90%
0.90%
Hold
49 68.88K $9.44M 0.89%
0.89%
Reduce
50 288.12K $9.34M 0.88%
0.88%
Add

FAQ

What did Ranger Investment Management, L.P. buy in 2026-Q3?

In its 2026-Q3 13F filing, Ranger Investment Management, L.P. reported 85 equity positions worth $1.07B in aggregate; its largest disclosed positions were LGND ($57.99M), PDFS ($38.27M), WLDN ($27.55M).

How large is Ranger Investment Management, L.P.'s portfolio?

Ranger Investment Management, L.P. reported $1.07B of long equity holdings across 85 positions as of 2026-Q3. Top-10 holdings account for 27.4% of reported value.

What is Ranger Investment Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ranger-investment-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →